[1] |
Cunningham EL,McGuinness B,Herron B, et al. Dementia[J]. Ulster Med J, 2015, 84(2): 79-87.
|
[2] |
Szeto GL,Pomerantz JL,Graham DR, et al. Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+Tcells[J]. J Biol Chem, 2011, 286(13): 11275-11282.
|
[3] |
Ferretti MT,Allard S,Partridge V, et al. Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer′s disease-like amyloid pathology[J]. J Neuroinflammation, 2012, 9: 62.
|
[4] |
Kalaria RN. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer′s disease[J]. Acta Neuropathol, 2016, 131(5): 659-685.
|
[5] |
Choi DH,Lee KH,Lee J. Effect of exercise-induced neurogenesis on cognitive function deficit in a rat model of?vascular dementia[J]. Mol Med Rep, 2016, 13(4): 2981-2990.
|
[6] |
Garrido-Mesa N,Zarzuelo A,Galvez J. Minocycline: far beyond an antibiotic[J]. Br J Pharmacol, 2013, 169(2): 337-352.
|
[7] |
Ma J,Zhang J,Hou WW, et al. Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion[J]. Sci Rep, 2015, 5: 12079.
|
[8] |
Zhang L,Li K,Sun R, et al. Minocycline ameliorates cognitive impairment induced by whole-brain irradiation: an animal study[J]. Radiat Oncol, 2014, 9: 281.
|
[9] |
Parachikova A,Vasilevko V,Cribbs DH, et al. Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation[J]. J Alzheimers Dis, 2010, 21(2): 527-542.
|
[10] |
Sun JH,Tan L,Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management[J]. Ann Transl Med, 2014, 2(8): 80.
|
[11] |
Jha SK,Jha NK,Kar R, et al. p38 MAPK and PI3K/AKT signalling cascades in Parkinson's disease[J]. Int J Mol Cell Med, 2015, 4(2): 67-86.
|
[12] |
Lazzara CA,Kim YH. Potential application of lithium in Parkinson′s and other neurodegenerative diseases[J]. Front Neurosci, 2015, 9: 403.
|